iHuman (NYSE:IH – Get Free Report) issued its quarterly earnings results on Monday. The company reported $0.06 earnings per share (EPS) for the quarter, Zacks reports. iHuman had a net margin of 12.46% and a return on equity of 11.59%.
iHuman Trading Down 3.7%
IH stock opened at $2.21 on Monday. The business’s fifty day moving average price is $2.60 and its 200 day moving average price is $2.69. iHuman has a 12-month low of $1.55 and a 12-month high of $3.60. The company has a market capitalization of $113.23 million, a PE ratio of 7.60 and a beta of -0.07.
Institutional Trading of iHuman
An institutional investor recently bought a new position in iHuman stock. Acadian Asset Management LLC purchased a new position in shares of iHuman Inc. Sponsored ADR (NYSE:IH – Free Report) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 15,067 shares of the company’s stock, valued at approximately $32,000. Institutional investors own 4.92% of the company’s stock.
Analyst Ratings Changes
Check Out Our Latest Analysis on IH
About iHuman
iHuman Inc provides intellectual development products to individual users, kindergartens, and distributors in the People’s Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Writing, iHuman Fantastic Friends, and iHuman Readers; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, and Gogo Town; and Aha World, an open-ended interactive app that nurtures a desire for discovery.
See Also
- Five stocks we like better than iHuman
- Do not delete, read immediately
- How the Rich Retire
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- How Long Will $1M Last in Retirement?
- [No Brainer Gold Play]: “Show me a better investment.”
Receive News & Ratings for iHuman Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iHuman and related companies with MarketBeat.com's FREE daily email newsletter.
